icon_loop icon_cart icon_arrow-down icon_pick-winners icon_make-better-decisions icon_gofaster-gosmarter icon_equio icon_custom-research icon_conquer-the-wild icon_be-anonymous-and-secure icon_analyst-reports icon_access-realtime-data icon_youtube icon_twitter icon_linkedin icon_facebook

Hemp Stocks: A Look at Leading Public Hemp Companies

By William Sumner, Hemp Business Journal Contributor Last week, the hemp industry was abuzz with the news that the United States Drug Enforcement Administration (DEA) would move Epidiolex, a CBD-based drug derived from cannabis, from a Schedule I substance to a Schedule V substance. The scheduling does not explicitly pertain to CBD, but it does […]
Read more

Awaiting Word on Rescheduling, the Market Watches Epidiolex

By William Sumner, Hemp Business Journal Contributor Pending word at any time, the United States Drug Enforcement Administration (DEA) is expected to reschedule Epidiolex, a CBD-based drug derived from cannabis. An announcement was due on Sept. 23, but by press time remained forthcoming. Manufactured by the London-based GW Pharmaceuticals, the drug has been shown to […]
Read more

Navigating the Maze of the Cannabis Market After the Daze of Summer

By J.J. McCoy, Senior Managing Editor, for New Frontier Data Even before word of the DEA’s landmark rescheduling of cannabidiol (CBD) for GW Pharmaceutical’s FDA-approved Epidiolex, the cannabis market has had a hot summer. Medical cannabis is now legal in 31 states and the District of Columbia, with adult-use markets open in 9 of them plus […]
Read more

Despite Bumps, CBD Market Growing Toward Convenience Store Shelves

By William Sumner, Hemp Business Journal Contributor The potential both practical and profitable for cannabidiol (CBD) has been gaining an increasing amount of national attention. From alleviating intractable seizures to soothing anxiety, CBD’s health benefits have (anecdotally) become well known, which has translated to millions of dollars’ worth of investment from entrepreneurs and [...]
Read more

States Challenged to Optimize Cannabis Tax Revenues

Some reinventing the cannabis tax-reform wheel as they go along By Tracy Curley, Partner at Cohnreznick The legal status of cannabis presents a challenge toward advancements in quality assurance and medical research. Currently, the Controlled Substance Act carries no distinction between the medical and recreational uses of cannabis, which is classified as a Schedule I […]
Read more

Recognizing Banking Risks in Emerging Cannabis Business Ventures

By Zoe Grimaldi, Executive Coordinator and J.J. McCoy, Senior Managing Editor, for New Frontier Data In 2014, Sundie Seefried founded Safe Harbor Services, the nation’s first federally compliant cannabis banking program. Safe Harbor enables financial institutions to extend business banking solutions to cannabis-related businesses (CRBs). Nearly five years later, Seefried, now the CEO of [...]
Read more

Going in Circles Over ‘The Hemp Loophole’

California’s crackdown on CBD in food may be toothless By J.J. McCoy, Senior Managing Editor for New Frontier Data In July, the California Department of Public Health’s Food and Drug Branch (CDPH-FDB) threw the burgeoning cannabidiol (CBD) industry into some frenzy by issuing a revised FAQ on CBD in food products, declaring that it cannot be […]
Read more

Charlotte’s Web Holdings (CNSX: CWEB) Quietly Raises $100 Million in IPO

By William Sumner, Hemp Business Journal Contributor It has been a busy, yet quiet week for the hemp-based CBD oil producer Charlotte’s Web Holdings, Inc. On August 30, 2018, the company reported the successful closing of its previously announced initial public offering (IPO), as well as a secondary offering of its common shares. Charlotte’s Web […]
Read more

How to Avoid Investor Disconnect

By Jeffrey E. Finkle I recently was asked to judge a pitching competition for CannInvest NJ. The format was familiar, each participant was given eight minutes to pitch their business idea to a panel of judges and an audience of on-lookers. The judges gave feedback and voted to determine a winner. Most of the presentations […]
Read more

Mass Overdoses from Synthetic Marijuana Remind Need for Public Education

By New Frontier Data Wednesday’s reported mass overdose on synthetic cannabinoids by nearly 80 people near Yale University – on the heels of 300 reported cases in a two-week span in Washington, D.C – serves as stark reminder to public health officials and the legal cannabis industry at large the need for better awareness and […]
Read more